Response to Letters to the Editor regarding "Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age"

Paediatr Anaesth. 2024 Apr;34(4):381-382. doi: 10.1111/pan.14832. Epub 2023 Dec 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Child
  • Humans
  • Sugammadex*

Substances

  • Sugammadex